InvestorsHub Logo
Followers 5
Posts 307
Boards Moderated 0
Alias Born 02/16/2006

Re: rx7171 post# 1177

Wednesday, 12/06/2006 10:50:23 AM

Wednesday, December 06, 2006 10:50:23 AM

Post# of 7719
'rx7171'

I appreciate your comments, I’m just sorry that you haven’t the time to DD this company. You appear to be quite qualified to give some perspective on a company that has the potential to advance beyond GERN. Their propriety research derived from the University of Stanford and Nebraska has shown great advances in combining new large-molecule delivery technologies with biomedical agents shown to lengthen chromosomal telomeres in vitro, successful in vivo therapies might be developed that significantly offset, and potentially reverse many age-related diseases and address symptoms and signs recognized as human aging. Good luck with GERN, perhaps these two companies will be working together.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GERN News